Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2022Frontiers in PharmacologyOpen Access

Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

YYYuanming YangQingdao UniversityYHYiwei HuaBeijing Institute of TechnologyWCWeihuan ChenGuangzhou University of Chinese Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yang et al. (2022) studied this question.

synapsesocial.com/papers/6a737bbf50ef228d5e6c3606https://doi.org/10.3389/fphar.2022.1037856
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders2017 · 1,939 citations
  2. 2Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance2020 · 254 citations
  3. 3Somatic mutation profiles as molecular classifiers of ulcerative colitis‐associated colorectal cancer2021 · 14 citations
  4. 4Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway2018 · 251 citations
  5. 5Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking2022 · 23 citations